What is ADAPY's gross margin?

Adaptimmune (ADAPY) has a gross margin of 82% and a net margin of -222%.

What is ADAPY's P/E ratio?

Track Adaptimmune (ADAPY) P/E ratio, ROE, and valuation metrics over time.

Where can I see ADAPY's full financials?

See Adaptimmune (ADAPY) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Adaptimmune (ADAPY) Financials — Revenue, Earnings, Cash Flow

Also trades as: ADAP (NASDAQ) · $vol 5M

$0.04

-0.00 (-2.63%)

Weekly Expected Move ±21.4%

$0 $0 $0 $0 $0

OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 55 · $9.8M mcap · 265M float · 0.149% daily turnover · Short 11% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$65M

Revenue

-54.0% YoY

$-170M

Net Income

-132.8% YoY

$-192M

Free Cash Flow

-311.3% YoY

81.7%

Gross Margin

-221.5%

Op. Margin

-221.8%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-1341.1%

ROA-75.1%

ROIC268.4%

Valuation

P/E-0.1

P/B-0.1

EV/EBITDA-0.6

Leverage

Debt/Equity-0.69

Current Ratio1.52

Interest Cov.-28.3x

Quality Scores

Piotroski F0/9

Altman Z-15.68

Beneish M6.09